Viewing Study NCT00274495


Ignite Creation Date: 2025-12-24 @ 1:33 PM
Ignite Modification Date: 2026-01-04 @ 2:20 PM
Study NCT ID: NCT00274495
Status: TERMINATED
Last Update Posted: 2007-11-01
First Post: 2006-01-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Assessing the Efficacy and Safety of Rosiglitazone Added to Standard Therapy for Hepatitis C Genotype 1 With Fatty Liver
Sponsor: Beth Israel Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module